Liberata Mwita

Liberata Mwita

Auto-generated profile, based on publicly available information

Liberata Mwita

Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CGChun-Jie Guo
Chun-Jie Guo
UAUma P. Arora
Uma P. Arora
WXWanying Xu
Wanying Xu
XCXiaoheng Cheng
Xiaoheng Cheng
LCLiam D. Cato
Liam D. Cato
VSVijay G. Sankaran
Vijay G. Sankaran
Human genetic studies have identified key regulators of fetal hemoglobin (HbF) expression, including BCL11A, resulting in therapeutic advances. Yet the mechanisms by which HbF expression is activated remain incompletely understood. Here, we conduct a multi-ancestry genome-wide association study of HbF levels in 28,237 individuals that identifies 131 conditionally-independent associations across 12 genomic regions. In one previously uncharacterized associated region, the high-HbF-linked causal variant, rs1010474-C, reduces BACH2 expression and elevates HbF levels. Direct perturbation or inhibition of BACH2 elevates HbF expression. Mechanistically, BACH2 restrains activation of the HbF-encoding γ -globin genes, while loss of BACH2 enhances NRF2 chromatin occupancy and promotes activation foci formation at the γ -globin genes. BACH2 and NRF2 binding motifs in the γ -globin promoters, while overlapping, can be selectively edited to activate or repress γ -globin, respectively, and function independently of BCL11A. These findings illustrate how human genetic variation continues to advance our knowledge of therapeutically-relevant regulatory mechanisms underlying HbF expression.

23 February 2023 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
LMLiberata A Mwita
Liberata A Mwita
WMWilliam F Mawalla
William F Mawalla
FMFrank R Mtiiye
Frank R Mtiiye
DKDaniel Kandonga
Daniel Kandonga
JKJill Kent
Jill Kent
Raphael Z. SangedaRaphael Z. Sangeda
Raphael Z. Sangeda
Sickle cell disease (SCD) is a common genetic disorder in Africa. Some ongoing work in SCD research includes the analysis and comparisons of variation in phenotypic presentations and disease outcomes with the genotypic signatures. This has contributed to the observed growth of molecular and genetic data in SCD. However, while the “omics” data continues to pile, the capacity to interpret and turn the genetic findings into clinical practice is still underdeveloped, especially in the developing region. Building bioinformatics infrastructure and capacity in the region is key to bridging the gap. This paper seeks to illustrate how the Sickle Cell Programme (SCP) at the Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania, modeled the integration of infrastructure for bioinformatics and clinical research while running day-to-day clinical care for SCD in Tanzania.

1 January 2023 in Global Health, Epidemiology and Genomics
Verified
Journal Article
Open access
PDF file
LZLyndon Zass
Lyndon Zass
KJKatherine Johnston
Katherine Johnston
ABAlia Benkahla
Alia Benkahla
MCMelek Chaouch
Melek Chaouch
JKJudit kumuthini
Judit kumuthini
NMNicola Mulder
Nicola Mulder
Modern biomedical research is characterised by its high‐throughput and interdisciplinary nature. Multiproject and consortium‐based collaborations requiring meaningful analysis of multiple heterogeneous phenotypic datasets have become the norm; however, such analysis remains a challenge in many regions across the world. An increasing number of data harmonisation efforts are being undertaken by multistudy collaborations through either prospective standardised phenotype data collection or retrospective phenotype harmonisation. In this regard, the Phenotype Harmonisation Working Group (PHWG) of the Human Heredity and Health in Africa (H3Africa) consortium aimed to facilitate phenotype standardisation by both promoting the use of existing data collection standards (hosted by PhenX), adapting existing data collection standards for appropriate use in low‐ and middle‐income regions such as Africa, and developing novel data collection standards where relevant gaps were identified. Ultimately, the PHWG produced 11 data collection kits, consisting of 82 protocols, 38 of which were existing protocols, 17 were adapted, and 27 were novel protocols. The data collection kits will facilitate phenotype standardisation and harmonisation not only in Africa but also across the larger research community. In addition, the PHWG aims to feed back adapted and novel protocols to existing reference platforms such as PhenX.

18 May 2023 in medRxiv
Verified
Preprint
Open access
PDF file
OOOyesola O. Ojewunmi
Oyesola O. Ojewunmi
TATitilope A. Adeyemo
Titilope A. Adeyemo
AOAjoke I. Oyetunji
Ajoke I. Oyetunji
BIBassey Inyang
Bassey Inyang
AAAfolashade Akinrindoye
Afolashade Akinrindoye
SMStephan Menzel
Stephan Menzel
Background: The clinical severity of sickle cell disease (SCD) is strongly influenced by the level of fetal haemoglobin (HbF) persistent in each patient. Three major HbF loci ( BCL11A , HBS1L-MYB , and Xmn1-HBG2 ) have been reported, but a considerable hidden heritability remains. Aim: Building on the power of a large and genetically diverse patient pool present in Nigeria, we conducted a genome-wide association study for HbF levels in patients from three regions of the country with a diverse ethnic make-up. Methods: We analysed genome-wide trait association in 1006 Nigerian patients with SCD (HbSS/HbSβ 0 ), followed by a replication and meta-analysis exercise in four independent SCD cohorts (3,582 patients). To dissect association signals at the major loci, we performed stepwise conditional analysis, haplotype association analysis and included public functional annotation data (fGCTA). Results: Association signals were detected for BCL11A (lead SNP rs6706648, β=- 0.39, P =4.96 x 10 -34 ) and HBS1L-MYB (lead SNP rs61028892, β=0.73, P =1.18 x 10 -9 ), whereas the variant allele for Xmn1-HBG2 was found to be very rare. Genetically dissecting the two major loci, we defined trait-boosting haplotypes containing suspected or so-far unidentified causal variants. At BCL11A , one such haplotype (trait increase P < 0.0001) contains the putative functional variant rs1427407-‘T’ and a second haplotype ( P < 0.0001) is tagged by the rs7565301-‘A’ allele, with no obvious candidate causal variant. At HBS1L- MYB , one haplotype (trait increase P < 0.0001) contains the likely functional rs66650371 (Δ3-bp), and a second ( P < 0.0001) is tagged by the ‘C’ allele of rs6102889. Together, variants at BCL11A and HBS1L-MYB SNPs explained 24.1% of the trait variance. We detected three novel association signals: SLC28A3 on chromosome 9 (rs115555854: β=- 0.73, P =2.52 x 10 -8 ), TICRR on chromosome 15 (rs140496989: β=-0.43, P =3.34 x 10 -8 ), and PIEZO2 on chromosome 18 (rs58817161: β= −0.63, P = 8.04 x 10 -8 ). These appeared to be restricted to the Nigerian patient cohort and were not confirmed in the replication cohorts. Conclusions: Studying a diverse cohort of Nigerian patients with sickle cell disease, we genetically dissected the known fetal-haemoglobin loci BCL11A and HBS1L-MYB and detected putative new trait-associated regions.


28 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Raphael Z. SangedaRaphael Z. Sangeda
Raphael Z. Sangeda
UMUpendo Masamu
Upendo Masamu
DKDaniel Kandonga
Daniel Kandonga
FMFredrick Mbuya
Fredrick Mbuya
LMLiberata Mwita
Liberata Mwita
JMJulie Makani
Julie Makani
Objective To document the deployment and training of Research Electronic Data Capture (REDCap) at Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania and to evaluate user satisfaction and perceived impact on research practices in Tanzania. Materials and Methods Six structured REDCap training workshops were conducted between 2016 and 2022. The post-training evaluation surveys were completed by 110 participants. Descriptive statistics were generated for demographics and cadres, while Likert-scale responses assessed satisfaction and perceived utility. Diverging stacked bar charts were used to visualize attitudes toward adopting REDCap. Results Most trainees were male (62.7%), aged 26–32 years (52.7%), and affiliated with MUHAS (66.4%), with additional representation from Ghana and Nigeria. The participants included academic or research staff (41.8%), postgraduate students (28.2%), undergraduate students (11.8%), and other professionals (18.2%). Post-training evaluations indicated consistently high satisfaction, with mean scores above 4.4 on a 5-point scale. Trainees strongly endorsed REDCap’s ability to enhance research effectiveness (mean 4.53, SD 0.65), increase productivity (mean 4.52, SD 0.69), and improve task completion (mean 4.50, SD 0.68). More than 85% of the respondents agreed or strongly agreed with the positive statements, underscoring the broad acceptance of REDCap as a reliable tool for research data management. Discussion The findings underscore the importance of structured training in mitigating barriers to adoption and enhancing data quality, efficiency, and institutional visibility. Conclusion Structured REDCap training in Tanzania was associated with high user satisfaction and perceived improvements in research productivity and data quality, offering a scalable model for strengthening data management capacity in sub-Saharan Africa.